> top > docs > PMC:7187660 > spans > 69-3772 > annotations

PMC:7187660 / 69-3772 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T2 66-74 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T3 502-510 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T4 603-611 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T5 614-623 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T6 841-849 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T7 1139-1161 Disease denotes cardiovascular disease http://purl.obolibrary.org/obo/MONDO_0004995
T8 1205-1217 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T9 1261-1269 Disease denotes diabetes http://purl.obolibrary.org/obo/MONDO_0005015
T10 1313-1332 Disease denotes respiratory disease http://purl.obolibrary.org/obo/MONDO_0005087
T11 1483-1491 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T12 1558-1566 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T13 2398-2410 Disease denotes Hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T14 2479-2487 Disease denotes Diabetes http://purl.obolibrary.org/obo/MONDO_0005015
T15 2553-2575 Disease denotes Cardiovascular disease http://purl.obolibrary.org/obo/MONDO_0004995
T16 2640-2659 Disease denotes Respiratory disease http://purl.obolibrary.org/obo/MONDO_0005087
T17 2722-2728 Disease denotes Cancer http://purl.obolibrary.org/obo/MONDO_0004992
T18 3061-3069 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 84-87 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T2 93-94 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T3 359-361 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T4 544-545 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T5 671-673 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T6 1001-1005 http://purl.obolibrary.org/obo/UBERON_0003101 denotes male
T7 1001-1005 http://www.ebi.ac.uk/efo/EFO_0000970 denotes male
T8 1053-1059 http://purl.obolibrary.org/obo/UBERON_0003100 denotes female
T9 1742-1745 http://purl.obolibrary.org/obo/CLO_0001414 denotes 548
T10 1817-1819 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T11 2247-2251 http://purl.obolibrary.org/obo/UBERON_0003101 denotes Male
T12 2247-2251 http://www.ebi.ac.uk/efo/EFO_0000970 denotes Male
T13 2324-2330 http://purl.obolibrary.org/obo/UBERON_0003100 denotes Female
T14 2660-2663 http://purl.obolibrary.org/obo/CLO_0001405 denotes 511
T15 2849-2852 http://purl.obolibrary.org/obo/CLO_0001445 denotes 617
T16 2958-2959 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T17 2973-2974 http://purl.obolibrary.org/obo/CLO_0001021 denotes b
T18 3097-3101 http://purl.obolibrary.org/obo/UBERON_0003101 denotes male
T19 3097-3101 http://www.ebi.ac.uk/efo/EFO_0000970 denotes male
T20 3115-3116 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T21 3159-3165 http://purl.obolibrary.org/obo/UBERON_0003100 denotes female
T22 3236-3237 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T23 3496-3497 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T24 3596-3600 http://purl.obolibrary.org/obo/UBERON_0003101 denotes male
T25 3596-3600 http://www.ebi.ac.uk/efo/EFO_0000970 denotes male

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 1001-1005 Chemical denotes male http://purl.obolibrary.org/obo/CHEBI_30780
T2 1070-1072 Chemical denotes RR http://purl.obolibrary.org/obo/CHEBI_73811
T3 1163-1165 Chemical denotes RR http://purl.obolibrary.org/obo/CHEBI_73811
T4 1271-1273 Chemical denotes RR http://purl.obolibrary.org/obo/CHEBI_73811
T5 1334-1336 Chemical denotes RR http://purl.obolibrary.org/obo/CHEBI_73811
T6 1389-1391 Chemical denotes RR http://purl.obolibrary.org/obo/CHEBI_73811
T7 1663-1665 Chemical denotes RR http://purl.obolibrary.org/obo/CHEBI_73811
T8 2823-2828 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T9 2874-2879 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T10 2909-2914 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T11 3097-3101 Chemical denotes male http://purl.obolibrary.org/obo/CHEBI_30780
T12 3596-3600 Chemical denotes male http://purl.obolibrary.org/obo/CHEBI_30780

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T2 0-160 Sentence denotes Using meta-analysis to explore clinical determinants for death of COVID-19 patients has been a problem due to insufficient sample size and overlapped cases [1].
T3 161-434 Sentence denotes In the study, we re-analyzed the largest confirmed case series reported publicly by the Chinese center for disease control and prevention (44,672 laboratory confirmed cases updated through February 11, 2020, [2]), to explore the clinical risk factors associated with death.
T4 435-537 Sentence denotes The basic characteristics between survivors and non-survivors with COVID-19 were presented in Table 1.
T5 538-707 Sentence denotes Among a total of 44,672 patients with laboratory confirmation of SARS-CoV-2 infection, 1023 (2.3%) patients were dead as of February 11, 2020, the last day of follow-up.
T6 708-822 Sentence denotes The fatality rate was increasing with ages and even up to 14.8% in patients aged above 80 years old (see Fig. 1a).
T7 823-970 Sentence denotes The prevalence of COVID-19 between men and women was pretty close (51.4% vs. 48.6%), which is different from previous report (58.1% vs. 41.9%) [3].
T8 971-1125 Sentence denotes Notably, the fatality rate of male patients was significantly higher than that of female patients (RR = 1.67, 95%CI = 1.47–1.89, p < 0.001) (see Fig. 1b).
T9 1126-1492 Sentence denotes Furthermore, cardiovascular disease (RR = 6.75, 95%CI = 5.40–8.43, p < 0.001), hypertension (HR = 4.48, 95%CI = 3.69–5.45, p < 0.001), diabetes (RR = 4.43, 95%CI = 3.49–5.61, p < 0.001), respiratory disease (RR = 3.43, 95%CI = 2.42–4.87, p < 0.001), and cancers (RR = 2.926, 95%CI = 1.34–6.41, p = 0.006) were the risk factors for fatality of patients with COVID-19.
T10 1493-1566 Sentence denotes Table 1 Characteristics between survivors and non-survivors with COVID-19
T11 1567-1675 Sentence denotes Characteristics Total (n = 44,672) Non-survivors (n = 1023) Survivors (n = 43,649) Fatality (%) RR (95%CI) p
T12 1676-1686 Sentence denotes Age, n (%)
T13 1687-1716 Sentence denotes  0– 416 (0.9%) 0 416 (0.9%) 0
T14 1717-1756 Sentence denotes  10– 549 (1.2%) 1 (0.1%) 548 (1.3%) 0.2
T15 1757-1798 Sentence denotes  20– 3619 (8.1%) 7 (0.7%) 3612 (8.3%) 0.2
T16 1799-1843 Sentence denotes  30– 7600 (17.0%) 18 (1.8%) 7582 (17.4%) 0.2
T17 1844-1888 Sentence denotes  40– 8571 (19.2%) 38 (3.7%) 8533 (19.5%) 0.4
T18 1889-1937 Sentence denotes  50– 10,008 (22.4%) 130 (12.7%) 9878 (22.6%) 1.3
T19 1938-1984 Sentence denotes  60– 8583 (19.2%) 309 (30.2%) 8274 (19.0%) 3.6
T20 1985-2029 Sentence denotes  70– 3918 (8.8%) 312 (30.5%) 3606 (8.3%) 8.0
T21 2030-2076 Sentence denotes  ≥ 80 1408 (3.2%) 208 (20.3%) 1200 (2.7%) 14.8
T22 2077-2093 Sentence denotes Severity*, n (%)
T23 2094-2142 Sentence denotes  Mild/moderate 36,160 (80.9%) 0 36,160 (82.8%) 0
T24 2143-2180 Sentence denotes  Severe 6168 (13.8%) 0 6168 (14.1%) 0
T25 2181-2231 Sentence denotes  Critical 2087 (4.7%) 1023 (100%) 1064 (2.4%) 49.0
T26 2232-2245 Sentence denotes Gender, n (%)
T27 2246-2322 Sentence denotes  Male 22,981 (51.4%) 653 (63.8%) 22,328 (51.2%) 2.8 1.67 (1.47–1.89) < 0.001
T28 2323-2376 Sentence denotes  Female 21,691 (48.6%) 370 (36.2%) 21,321 (48.8%) 1.7
T29 2377-2396 Sentence denotes Comorbidity#, n (%)
T30 2397-2477 Sentence denotes  Hypertension 2683 (12.8%) 161 (39.7%) 2522 (12.3%) 6.0 4.48 (3.69–5.45) < 0.001
T31 2478-2551 Sentence denotes  Diabetes 1102 (5.3%) 80 (19.7%) 1022 (5.0%) 7.3 4.47 (3.49–5.61) < 0.001
T32 2552-2638 Sentence denotes  Cardiovascular disease 873 (4.2%) 92 (22.7%) 781 (3.8%) 10.5 6.75 (5.40–8.43) < 0.001
T33 2639-2720 Sentence denotes  Respiratory disease 511 (2.4%) 32 (7.9%) 479 (2.3%) 6.3 3.43 (2.42–4.87) < 0.001
T34 2721-2786 Sentence denotes  Cancer 107 (0.5%) 6 (1.5%) 101 (0.5%) 5.6 2.93 (1.34–6.41) 0.006
T35 2787-2829 Sentence denotes *Missing data (n = 257 in survivors group)
T36 2830-2915 Sentence denotes #Missing data (n = 617 in the non-survivors group, n = 23,073 in the survivors group)
T37 2916-2989 Sentence denotes Fig. 1 Fatality rate distribution of age (a) and gender (b). ***p < 0.001
T38 2990-3175 Sentence denotes In summary, we found that there was no difference in the prevalence of COVID-19 between men and women, but male patients had a nearly 1.7-fold higher risk of death than female patients.
T39 3176-3268 Sentence denotes Moreover, we concluded that patients with comorbidities had a significantly high death risk.
T40 3269-3470 Sentence denotes Admittedly, due to the unavailability of individual patient data, we could not exclude the influence of age on the conclusion because old patients were more likely to have the underlying comorbidities.
T41 3471-3639 Sentence denotes We would like to provide a reminder to the physicians that more intensive surveillance or treatment should be considered for male patients and those with comorbidities.
T42 3640-3703 Sentence denotes Further and larger studies are needed to validate the findings.

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 1139-1161 Phenotype denotes cardiovascular disease http://purl.obolibrary.org/obo/HP_0001626
T2 1205-1217 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T3 2398-2410 Phenotype denotes Hypertension http://purl.obolibrary.org/obo/HP_0000822
T4 2553-2575 Phenotype denotes Cardiovascular disease http://purl.obolibrary.org/obo/HP_0001626
T5 2722-2728 Phenotype denotes Cancer http://purl.obolibrary.org/obo/HP_0002664

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T2 57-62 GO:0016265 denotes death
T3 66-74 SP_7 denotes COVID-19
T4 276-283 GO:0065007 denotes control
T5 428-433 GO:0016265 denotes death
T6 502-510 SP_7 denotes COVID-19
T7 603-613 SP_7 denotes SARS-CoV-2
T8 841-849 SP_7 denotes COVID-19
T9 1139-1153 UBERON:0004535 denotes cardiovascular
T10 1313-1324 UBERON:0001004 denotes respiratory
T11 1483-1491 SP_7 denotes COVID-19
T12 1558-1588 SP_7 denotes COVID-19 Characteristics Total
T13 2553-2567 UBERON:0004535 denotes Cardiovascular
T15 3061-3069 SP_7 denotes COVID-19
T16 3148-3153 GO:0016265 denotes death
T17 3257-3262 GO:0016265 denotes death
T18 3545-3557 GO:0065007 denotes surveillance
T14874 57-62 GO:0016265 denotes death
T65338 66-74 SP_7 denotes COVID-19
T80647 276-283 GO:0065007 denotes control
T90898 428-433 GO:0016265 denotes death
T89898 502-510 SP_7 denotes COVID-19
T58247 603-613 SP_7 denotes SARS-CoV-2
T56005 841-849 SP_7 denotes COVID-19
T25359 1139-1153 UBERON:0004535 denotes cardiovascular
T45386 1313-1324 UBERON:0001004 denotes respiratory
T24778 1483-1491 SP_7 denotes COVID-19
T56769 1558-1588 SP_7 denotes COVID-19 Characteristics Total
T38161 2553-2567 UBERON:0004535 denotes Cardiovascular
T89260 3061-3069 SP_7 denotes COVID-19
T78176 3148-3153 GO:0016265 denotes death
T31503 3257-3262 GO:0016265 denotes death
T26047 3545-3557 GO:0065007 denotes surveillance

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
8 75-83 Species denotes patients Tax:9606
9 57-62 Disease denotes death MESH:D003643
10 66-74 Disease denotes COVID-19 MESH:C000657245
11 428-433 Disease denotes death MESH:D003643
17 2398-2410 Disease denotes Hypertension MESH:D006973
18 2479-2487 Disease denotes Diabetes MESH:D003920
19 2553-2575 Disease denotes Cardiovascular disease MESH:D002318
20 2640-2659 Disease denotes Respiratory disease MESH:D012140
21 2722-2728 Disease denotes Cancer MESH:D009369
23 1558-1566 Disease denotes COVID-19 MESH:C000657245
41 562-570 Species denotes patients Tax:9606
42 637-645 Species denotes patients Tax:9606
43 775-783 Species denotes patients Tax:9606
44 858-861 Species denotes men Tax:9606
45 866-871 Species denotes women Tax:9606
46 1006-1014 Species denotes patients Tax:9606
47 1060-1068 Species denotes patients Tax:9606
48 1469-1477 Species denotes patients Tax:9606
49 502-510 Disease denotes COVID-19 MESH:C000657245
50 603-623 Disease denotes SARS-CoV-2 infection MESH:C000657245
51 841-849 Disease denotes COVID-19 MESH:C000657245
52 1139-1161 Disease denotes cardiovascular disease MESH:D002318
53 1205-1217 Disease denotes hypertension MESH:D006973
54 1261-1269 Disease denotes diabetes MESH:D003920
55 1313-1332 Disease denotes respiratory disease MESH:D012140
56 1380-1387 Disease denotes cancers MESH:D009369
57 1483-1491 Disease denotes COVID-19 MESH:C000657245
69 3078-3081 Species denotes men Tax:9606
70 3086-3091 Species denotes women Tax:9606
71 3102-3110 Species denotes patients Tax:9606
72 3166-3174 Species denotes patients Tax:9606
73 3204-3212 Species denotes patients Tax:9606
74 3321-3328 Species denotes patient Tax:9606
75 3407-3415 Species denotes patients Tax:9606
76 3601-3609 Species denotes patients Tax:9606
77 3061-3069 Disease denotes COVID-19 MESH:C000657245
78 3148-3153 Disease denotes death MESH:D003643
79 3257-3262 Disease denotes death MESH:D003643